Historical salary details - Dr. Briggs W. Morrison, M.D., Director, Werewolf Therapeutics Inc
Dr. Briggs W. Morrison, M.D. is the Director of Werewolf Therapeutics Inc. They also hold 3 other positions in Arvinas Inc, Repare Therapeutics Inc and Syndax Pharmaceuticals Inc.
Dr. Briggs W. Morrison, M.D.
Director
-
Gross Remuneration
-
Current Company
Werewolf Therapeutics Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Werewolf Therapeutics Inc | Director | - | - |
| 2024 | Arvinas Inc | Lead Independent Director | - | - |
| 2024 | Repare Therapeutics Inc | Independent Director | - | - |
| 2024 | Syndax Pharmaceuticals Inc | Director | - | - |
| 2023 | Arvinas Inc | Lead Independent Director | 383.5 K | 31.5 % |
| 2023 | Repare Therapeutics Inc | Independent Director | 268.8 K | -20.3 % |
| 2023 | Werewolf Therapeutics Inc | - | 62.3 K | -4.3 % |
| 2023 | Arvinas Inc | Lead Independent Director | - | - |
| 2023 | Syndax Pharmaceuticals Inc | Director | - | - |
| 2023 | Syndax Pharmaceuticals Inc | Director | - | - |
| 2022 | Repare Therapeutics Inc | Independent Director | 337.4 K | -28.1 % |
| 2022 | Arvinas Inc | Lead Independent Director | 291.7 K | -30.3 % |
| 2022 | Werewolf Therapeutics Inc | Independent Director | 65.1 K | -76.2 % |
| 2022 | Carisma Therapeutics Inc | Independent Director | - | - |
| 2022 | Syndax Pharmaceuticals Inc | Director, President and Head of Research and Devel | - | - |
| 2021 | Repare Therapeutics Inc | Independent Director | 469.0 K | 857.1 % |
| 2021 | Arvinas Inc | Independent Director | 418.3 K | 42.2 % |
| 2021 | Werewolf Therapeutics Inc | Independent Director | 274.1 K | - |
| 2021 | Nextcure Inc | - | 10 K | -96.1 % |
| 2021 | Syndax Pharmaceuticals Inc | President, Head of Research & Development and Dire | - | - |
| 2021 | Nextcure Inc | Independent Director | - | - |
| 2020 | Arvinas Inc | Independent Director | 294.0 K | 34.7 % |
| 2020 | Nextcure Inc | Independent Director | 259.0 K | 4.2 % |
| 2020 | Repare Therapeutics Inc | Independent Director | 49 K | -59.6 % |
| 2020 | Werewolf Therapeutics Inc | Independent Director | - | - |
| 2020 | Syndax Pharmaceuticals Inc | Chief Executive Officer and Director | - | - |
| 2019 | Nextcure Inc | Independent Director | 248.6 K | - |
| 2019 | Arvinas Inc | Independent Director | 218.2 K | -61.8 % |
| 2019 | Repare Therapeutics Inc | Director | 121.2 K | - |
| 2019 | Syndax Pharmaceuticals Inc | Chief Executive Officer and Director | - | - |
| 2018 | Arvinas Inc | Independent Director | 571.9 K | - |
| 2018 | Nextcure Inc | Director | - | - |
| 2018 | Syndax Pharmaceuticals Inc | Chief Executive Officer and Director | - | - |
| 2017 | Arvinas Inc | Independent Director | - | - |
| 2017 | Syndax Pharmaceuticals Inc | Chief Executive Officer and Director | - | - |
| 2016 | Syndax Pharmaceuticals Inc | Chief Executive Officer and Director | - | - |
| 2015 | Syndax Pharmaceuticals Inc | Chief Executive Officer and Director | - | - |